These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 26391765)
21. Nuclear localization sequence of FUS and induction of stress granules by ALS mutants. Gal J; Zhang J; Kwinter DM; Zhai J; Jia H; Jia J; Zhu H Neurobiol Aging; 2011 Dec; 32(12):2323.e27-40. PubMed ID: 20674093 [TBL] [Abstract][Full Text] [Related]
22. Arginine methylation by PRMT1 regulates nuclear-cytoplasmic localization and toxicity of FUS/TLS harbouring ALS-linked mutations. Tradewell ML; Yu Z; Tibshirani M; Boulanger MC; Durham HD; Richard S Hum Mol Genet; 2012 Jan; 21(1):136-49. PubMed ID: 21965298 [TBL] [Abstract][Full Text] [Related]
23. How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other? Baloh RH Curr Opin Neurol; 2012 Dec; 25(6):701-7. PubMed ID: 23041957 [TBL] [Abstract][Full Text] [Related]
24. FET proteins in frontotemporal dementia and amyotrophic lateral sclerosis. Mackenzie IR; Neumann M Brain Res; 2012 Jun; 1462():40-3. PubMed ID: 22261247 [TBL] [Abstract][Full Text] [Related]
25. Monomethylated and unmethylated FUS exhibit increased binding to Transportin and distinguish FTLD-FUS from ALS-FUS. Suárez-Calvet M; Neumann M; Arzberger T; Abou-Ajram C; Funk E; Hartmann H; Edbauer D; Kremmer E; Göbl C; Resch M; Bourgeois B; Madl T; Reber S; Jutzi D; Ruepp MD; Mackenzie IR; Ansorge O; Dormann D; Haass C Acta Neuropathol; 2016 Apr; 131(4):587-604. PubMed ID: 26895297 [TBL] [Abstract][Full Text] [Related]
26. Aggregation of FET Proteins as a Pathological Change in Amyotrophic Lateral Sclerosis. Furukawa Y; Tokuda E Adv Exp Med Biol; 2017; 925():1-12. PubMed ID: 27311318 [TBL] [Abstract][Full Text] [Related]
27. RRM adjacent TARDBP mutations disrupt RNA binding and enhance TDP-43 proteinopathy. Chen HJ; Topp SD; Hui HS; Zacco E; Katarya M; McLoughlin C; King A; Smith BN; Troakes C; Pastore A; Shaw CE Brain; 2019 Dec; 142(12):3753-3770. PubMed ID: 31605140 [TBL] [Abstract][Full Text] [Related]
28. Subcellular localization and RNAs determine FUS architecture in different cellular compartments. Yang L; Zhang J; Kamelgarn M; Niu C; Gal J; Gong W; Zhu H Hum Mol Genet; 2015 Sep; 24(18):5174-83. PubMed ID: 26123490 [TBL] [Abstract][Full Text] [Related]
29. Impaired nuclear transport induced by juvenile ALS causing P525L mutation in NLS domain of FUS: A molecular mechanistic study. Basu S; Rajendra KC; Alagar S; Bahadur RP Biochim Biophys Acta Proteins Proteom; 2022 Apr; 1870(4):140766. PubMed ID: 35134572 [TBL] [Abstract][Full Text] [Related]
30. Arginine methylation next to the PY-NLS modulates Transportin binding and nuclear import of FUS. Dormann D; Madl T; Valori CF; Bentmann E; Tahirovic S; Abou-Ajram C; Kremmer E; Ansorge O; Mackenzie IR; Neumann M; Haass C EMBO J; 2012 Nov; 31(22):4258-75. PubMed ID: 22968170 [TBL] [Abstract][Full Text] [Related]
31. Directly converted patient-specific induced neurons mirror the neuropathology of FUS with disrupted nuclear localization in amyotrophic lateral sclerosis. Lim SM; Choi WJ; Oh KW; Xue Y; Choi JY; Kim SH; Nahm M; Kim YE; Lee J; Noh MY; Lee S; Hwang S; Ki CS; Fu XD; Kim SH Mol Neurodegener; 2016 Jan; 11():8. PubMed ID: 26795035 [TBL] [Abstract][Full Text] [Related]
32. Nuclear transport impairment of amyotrophic lateral sclerosis-linked mutations in FUS/TLS. Ito D; Seki M; Tsunoda Y; Uchiyama H; Suzuki N Ann Neurol; 2011 Jan; 69(1):152-62. PubMed ID: 21280085 [TBL] [Abstract][Full Text] [Related]
33. RNA Binding Motif Protein RBM45 Regulates Expression of the 11-Kilodalton Protein of Parvovirus B19 through Binding to Novel Intron Splicing Enhancers. Wang J; Ganaie SS; Cheng F; Xu P; Ning K; Wang X; Kleiboeker S; Cheng S; Qiu J mBio; 2020 Mar; 11(2):. PubMed ID: 32156816 [TBL] [Abstract][Full Text] [Related]
35. Stress granules in neurodegeneration--lessons learnt from TAR DNA binding protein of 43 kDa and fused in sarcoma. Bentmann E; Haass C; Dormann D FEBS J; 2013 Sep; 280(18):4348-70. PubMed ID: 23587065 [TBL] [Abstract][Full Text] [Related]
36. Atypical FTLD-FUS associated with ALS-TDP: a case report. Kobayashi Z; Arai T; Yokota O; Tsuchiya K; Hosokawa M; Oshima K; Niizato K; Akiyama H; Mizusawa H Neuropathology; 2013 Feb; 33(1):83-6. PubMed ID: 22640227 [TBL] [Abstract][Full Text] [Related]
37. Localization of fused in sarcoma (FUS) protein to the post-synaptic density in the brain. Aoki N; Higashi S; Kawakami I; Kobayashi Z; Hosokawa M; Katsuse O; Togo T; Hirayasu Y; Akiyama H Acta Neuropathol; 2012 Sep; 124(3):383-94. PubMed ID: 22526020 [TBL] [Abstract][Full Text] [Related]
38. R521C and R521H mutations in FUS result in weak binding with Karyopherinβ2 leading to Amyotrophic lateral sclerosis: a molecular docking and dynamics study. Swetha RG; Ramaiah S; Anbarasu A J Biomol Struct Dyn; 2017 Aug; 35(10):2169-2185. PubMed ID: 27381509 [TBL] [Abstract][Full Text] [Related]
39. FUS pathology in basophilic inclusion body disease. Munoz DG; Neumann M; Kusaka H; Yokota O; Ishihara K; Terada S; Kuroda S; Mackenzie IR Acta Neuropathol; 2009 Nov; 118(5):617-27. PubMed ID: 19830439 [TBL] [Abstract][Full Text] [Related]
40. Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation. Naumann M; Pal A; Goswami A; Lojewski X; Japtok J; Vehlow A; Naujock M; Günther R; Jin M; Stanslowsky N; Reinhardt P; Sterneckert J; Frickenhaus M; Pan-Montojo F; Storkebaum E; Poser I; Freischmidt A; Weishaupt JH; Holzmann K; Troost D; Ludolph AC; Boeckers TM; Liebau S; Petri S; Cordes N; Hyman AA; Wegner F; Grill SW; Weis J; Storch A; Hermann A Nat Commun; 2018 Jan; 9(1):335. PubMed ID: 29362359 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]